MU College of Veterinary Medicine to study efficacy of cancer drug in dogs

October 5, 2010, University of Missouri-Columbia

A cancer drug that benefits people may soon benefit man's best friend.

Kim Selting, assistant teaching professor of oncology at the MU College of Veterinary Medicine, is the principal investigator in a study that examines the efficacy of Attaxol™ in dogs with naturally occurring cancer. Attaxol was developed, and is produced, by CritiTech, a Lawrence, Kan. drug development company.

Kim Selting, assistant teaching professor of oncology at the MU College of Veterinary Medicine.

"Cancer is one of the most common causes of death in dogs," Selting said. "This study is important because most chemotherapy drugs available to people can be used in dogs, except for the highly successful taxanes that can keep cancer from proliferating throughout the body. The Attaxol formulation is built specifically for dogs and could allow taxanes to be used by veterinarians."

MU veterinarians will conduct the clinical part of the study and assess cancer response in the dogs involved in the study. Data from an earlier safety study was used to establish a starting dose, and this second study will consist of an escalation phase to determine the optimal dose, followed by an extended treatment. CritiTech scientists will analyze blood samples to determine plasma levels of the drug during the course of treatment. Enrollment of in the study is set to start in mid October, and it is anticipated that the study will take about two years to complete.

The Scott Endowed Program in Veterinary Oncology at MU is one of the largest veterinary programs in the country and actively initiates and participates in clinical trials, as well as provides routine treatment of animals with cancer, including chemotherapy, cancer surgery and radiation therapy.

"We are excited about our continued collaboration with the University of Missouri College of Veterinary Medicine and the commercial opportunity to use CritiTech's fine-particle drug technology in the veterinary field," said Sam Campbell, CritiTech president and chairman.

Explore further: Veterinary oncologists advance cancer drugs for humans and pets

Related Stories

Dogs carrying hospital superbug

May 31, 2007

Veterinarians in Sweden say dogs may be spreading the MRSA superbug in veterinary clinics. The first Swedish case of a dog contracting the virus was recorded at a clinic in Stockholm last fall, The Local newspaper said Wednesday.

Recommended for you

Genome duplication drives evolution of species

September 25, 2018

Many wild and cultivated plants arise through the combination of two species. The genome of these so-called polyploid species often consists of a quadruple set of chromosomes—a double set for each parental species—and ...

Some female termites can reproduce without males

September 24, 2018

Populations of the termite species Glyptotermes nakajimai can form successful, reproducing colonies in absence of males, according to a study published in the open access journal BMC Biology.

Photosynthesis discovery could help next-gen biotechnologies

September 24, 2018

Researchers from The University of Queensland (UQ) and the University of Münster (WWU) have purified and visualized the 'Cyclic Electron Flow' (CEF) supercomplex, a critical part of the photosynthetic machinery in all plants, ...

How fruits got their eye-catching colors

September 24, 2018

Red plums. Green melons. Purple figs. Ripe fruits come in an array of greens, yellows, oranges, browns, reds and purples. Scientists say they have new evidence that plants owe their rainbow of fruit colors to the different ...

Custom circuits for living cells

September 24, 2018

A team of Caltech researchers has developed a biological toolkit of proteins that can be assembled together in different ways, like Legos, to program new behaviors in cells. As a proof-of-concept, they designed and constructed ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.